Back to companies
Vistagen Therapeutics, Inc.
VTGNUSNASDAQPharmaceuticals & HealthcareVistagen Therapeutics, Inc.
Revenue
$1.3mn
YoY +161.1%
Operating income
-$72.1mn
FY2026
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API